Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2016.4828
Abstract: Importance Patients with type 2 diabetes are at high risk of cardiovascular disease (CVD) in part owing to hypertriglyceridemia and low high-density lipoprotein cholesterol. It is unknown whether adding triglyceride-lowering treatment to statin reduces this… read more here.
Keywords: risk; therapy; patients type; study ... See more keywords
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2017.4228
Abstract: Importance An elevated level of urinary albumin to creatinine ratio (UACR) is a marker of renal dysfunction and predictor of kidney failure/death in patients with type 2 diabetes. The prognostic use of UACR in established… read more here.
Keywords: patients type; risk; trial; disease ... See more keywords
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2020.4511
Abstract: Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular (CV) and kidney outcomes; however, the consistency of outcomes across the class remains uncertain. Objective To perform meta-analyses that assess the CV and kidney outcomes of… read more here.
Keywords: sglt2 inhibitors; death; patients type; type diabetes ... See more keywords
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.0660
Abstract: Importance Sodium-glucose cotransporter 2 inhibitors, such as dapagliflozin, promote renal glucose excretion and reduce cardiovascular (CV) deaths and hospitalizations for heart failure (HHF) among patients with type 2 diabetes. The relative CV efficacy and safety… read more here.
Keywords: patients type; death; hhf; type diabetes ... See more keywords
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.2006
Abstract: Importance Dapagliflozin was shown to reduce the cardiovascular (CV) and kidney outcomes in patients with type 2 diabetes. However, data are limited on the relationship of the effect and safety with the concurrent use of… read more here.
Keywords: patients type; safety; kidney; type diabetes ... See more keywords
Associations of Serum Folate and Vitamin B12 Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.46124
Abstract: Key Points Question Are serum folate and vitamin B12 levels associated with cardiovascular disease (CVD) mortality among patients with type 2 diabetes? Findings In this cohort study of 8067 patients with type 2 diabetes, results… read more here.
Keywords: patients type; folate vitamin; mortality; vitamin b12 ... See more keywords
GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.26321
Abstract: This cohort study examines the occurrence of diabetic retinopathy, ischemic optic nerve disease, or other ocular complications within 2 years of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among patients with type 2 diabetes. read more here.
Keywords: patients type; receptor agonists; type diabetes; glp receptor ... See more keywords
Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2024.5219
Abstract: Importance Empagliflozin might lower the risk of diabetic retinopathy (DR) by preventing retinal pericyte loss. However, the role of empagliflozin with respect to DR in patients with type 2 diabetes (T2D) remains unclear. Objective To… read more here.
Keywords: cohort; history; patients type; progression ... See more keywords
Meta‐analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10724
Abstract: This study aimed to examine the effect of metabolic surgery on pre‐existing and future microvascular complications in patients with type 2 diabetes mellitus (T2DM) in comparison with medical treatment. Although metabolic surgery is the most… read more here.
Keywords: metabolic surgery; surgery; patients type; treatment ... See more keywords
The Prevalence of Coronary Microvascular Dysfunction in Patients With Type 2 Diabetes Mellitus
Sign Up to like & getrecommendations! Published in 2025 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.31429
Abstract: Patients with type 2 diabetes mellitus (DM) are more susceptible to microvascular complications. However, whether DM is associated with coronary microvascular dysfunction (CMD) is unclear. This observational study used data from the Coronary Microvascular Disease… read more here.
Keywords: coronary microvascular; physiology; patients type; diabetes mellitus ... See more keywords
Practical cardiovascular risk calculator for asymptomatic patients with type 2 diabetes mellitus: PRECISE‐DM risk score
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23405
Abstract: Obstructive coronary artery disease (OCAD) is a significant predictor of adverse clinical events in asymptomatic patients with type 2 diabetes mellitus (T2DM). read more here.
Keywords: patients type; risk; practical cardiovascular; type diabetes ... See more keywords